business newsMidday Nasdaq Up on Facebook, Intel During Conference Season
By
Jonah Loeb Sep 11, 2012 3:05 pm
Green Mountain Coffee continues to percolate.
PRINT
-
Stay Connected
-
-
-
-
MINYANVILLE ORIGINAL The Nasdaq Composite (^IXIC) rose 0.25% to 3,111.69 at 2:45 p.m. today on general optimism ahead of decisions that the Federal Reserve will make later this week.
Green Mountain Coffee (GMCR) continued its climb, rising 4.78% to $31.81 per share on news that one of its European investors, Italian coffee maker Luigi Lavazza S.p.A., had increased its stake in the company by 36%. Intel (INTC) rose 1.01% to $23.50 during its annual developers conference as executives made the case that Microsoft’s (MSFT) upcoming Windows 8 operating system would give Intel a boost. Microsoft itself rose 0.50% to $30.88.
Social media behemoth Facebook (FB) continued to claw its way out of the abyss, climbing 2.74% to $19.32 as investors got excited about Facebook’s integration with the upcoming iPhone 5 (yeah, yeah, but we all know that’s what it’s going to be called). Apple (AAPL) held steady ahead of its conference, falling just 0.11% to $662.00. Things weren’t so solid in the biotech sector, though; Peregrine Pharmaceuticals (PPHM) fell 8.27% to $3.98 per share on high volume as questions about some of its new drugs continued to arise.
Green Mountain Coffee (GMCR) continued its climb, rising 4.78% to $31.81 per share on news that one of its European investors, Italian coffee maker Luigi Lavazza S.p.A., had increased its stake in the company by 36%. Intel (INTC) rose 1.01% to $23.50 during its annual developers conference as executives made the case that Microsoft’s (MSFT) upcoming Windows 8 operating system would give Intel a boost. Microsoft itself rose 0.50% to $30.88.
Social media behemoth Facebook (FB) continued to claw its way out of the abyss, climbing 2.74% to $19.32 as investors got excited about Facebook’s integration with the upcoming iPhone 5 (yeah, yeah, but we all know that’s what it’s going to be called). Apple (AAPL) held steady ahead of its conference, falling just 0.11% to $662.00. Things weren’t so solid in the biotech sector, though; Peregrine Pharmaceuticals (PPHM) fell 8.27% to $3.98 per share on high volume as questions about some of its new drugs continued to arise.
No positions in stocks mentioned.
Daily Recap
Everything you need to know for the next trading day.
Trading Radar (weekly)
Your road map to all the events that will effect financial markets in the week ahead.
Name
Email
*
Phone
* required field
